• Title/Summary/Keyword: chronic inflammatory disease

Search Result 708, Processing Time 0.023 seconds

A Case Report of Chronic Pelvic Inflammatory Disease (만성 골반염에 대한 치험 1례(例) 보고)

  • Nam, Eun-Jung;Lee, Dong-Nyung;Kim, Hyung-Jun;Lee, Yeon-Kyeong
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.20 no.2
    • /
    • pp.205-213
    • /
    • 2007
  • Purpose: The purpose of this study is to report the effect of Korean Medicine therapy to chronic pelvic inflammatory disease. Methods: A 34 years old woman, who suffered from chronic pelvic inflammatory disease was admitted to the OBGY department of Se-Myung University, Je-Cheon. In the beginning of treatment, she had pain and cold in the lower abdomen, dysuria, displeasure of sexual intercourse, etc. She received Korean Medicine therapies such as herbal medicine, moxibustion, acupuncture and got good result from them. Results: As a result, symptoms are remarkably alleviated. Conclusion: The present study suggests that Korean Medicine therapies have significant effect on chronic pelvic inflammatory disease.

  • PDF

Analysis of Immune Response in Dogs with Chronic Inflammatory Skin Disease (만성 피부 염증소견을 보인 개의 면역학적 특성 분석 연구)

  • Cho, Sun-Ju;Koh, Min-Soo;Jung, Bock-Gie;Ko, Jae-Hyung;Yoon, So-Rah;Han, Dong-Un;Lee, Bong-Joo
    • Journal of Veterinary Clinics
    • /
    • v.26 no.5
    • /
    • pp.433-440
    • /
    • 2009
  • High levels of inflammatory cytokines were proposed contributors to the pathogenesis of a various inflammatory skin disorders. Therefore, investigating the immune response of the inflammatory skin disorder allows a better understanding of pathogenesis of a various inflammatory skin disorders and therapeutic approaches. The aim of this study was to analyze of the immune response in dogs with chronic inflammatory skin disease. To this aim, the present study evaluated relative mRNA expression of canine $IFN-{\gamma}$, IL-4, $TGF-{\beta}$ and IL-10 using TaqMan realtime PCR assays and semi-quantitative RT-PCR in freshly isolated peripheral blood mononuclear cells from twenty dogs with chronic inflammatory skin disease and ten normal dogs. The relative mRNA expression levels of IL-4 mRNA were significantly higher in dogs with chronic inflammatory skin disease than those in normal dogs (P < 0.01). The results of present study also showed a tendency towards increased expression of IL-10 transcripts in dogs with chronic inflammatory skin disease. However, there were no significant differences in the levels $IFN-{\gamma},\;TGF-{\beta}$ between normal and chronically inflammed dogs. In addition, the concentration of serum IgE was significantly increased in dogs with chronic inflammatory skin disease compared with those in normal dogs (P < 0.01). In histopathological examination, we found that there were markedly increased mast cell counts in chronically inflammed dogs (P < 0.05). These results suggest that the pathogenesis of chronic inflammatory skin disease might be associated with a T-cell mediated inflammatory responses characterized by a Th2-skewed immune response. Based on these results, the modulation of Th1/Th2 balance may be an effective therapeutic strategy for the treatment of chronic inflammatory skin disease.

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases

  • Annamneedi Venkata Prakash;Il-Ho Park;Jun Woo Park;Jae Pil Bae;Geum Seon Lee;Tae Jin Kang
    • Biomolecules & Therapeutics
    • /
    • v.31 no.4
    • /
    • pp.395-401
    • /
    • 2023
  • Innate immunity is a first line defence system in the body which is for sensing signals of danger such as pathogenic microbes or host-derived signals of cellular stress. Pattern recognition receptors (PRR's), which present in the cell memebrane, are suspect the infection through pathogen-associated molecular patterns (PAMP), and activate innate immunity with response to promote inflammation via inflammatory cells such as macrophages and neutrophils, and cytokines. Inflammasome are protein complexes which are part of innate immunity in inflammation to remove pathogens and repair damaged tissues. What is the important role of inflammation in disease? In this review, we are focused on the action mechanism of NLRP3 inflammasome in inflammatory diseases such as asthma, atopic dermatitis, and sepsis.

The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease

  • Nurwidya, Fariz;Damayanti, Triya;Yunus, Faisal
    • Tuberculosis and Respiratory Diseases
    • /
    • v.79 no.1
    • /
    • pp.5-13
    • /
    • 2016
  • Chronic obstructive pulmonary disease (COPD) is a chronic and progressive inflammatory disease of the airways and lungs that results in limitations of continuous airflow and is caused by exposure to noxious gasses and particles. A major cause of morbidity and mortality in adults, COPD is a complex disease pathologically mediated by many inflammatory pathways. Macrophages, neutrophils, dendritic cells, and CD8+ T-lymphocytes are the key inflammatory cells involved in COPD. Recently, the non-coding small RNA, micro-RNA, have also been intensively investigated and evidence suggest that it plays a role in the pathogenesis of COPD. Here, we discuss the accumulated evidence that has since revealed the role of each inflammatory cell and their involvement in the immunopathogenesis of COPD. Mechanisms of steroid resistance in COPD will also be briefly discussed.

Repositioned Drugs for Inflammatory Diseases such as Sepsis, Asthma, and Atopic Dermatitis

  • Prakash, Annamneedi Venkata;Park, Jun Woo;Seong, Ju-Won;Kang, Tae Jin
    • Biomolecules & Therapeutics
    • /
    • v.28 no.3
    • /
    • pp.222-229
    • /
    • 2020
  • The process of drug discovery and drug development consumes billions of dollars to bring a new drug to the market. Drug development is time consuming and sometimes, the failure rates are high. Thus, the pharmaceutical industry is looking for a better option for new drug discovery. Drug repositioning is a good alternative technology that has demonstrated many advantages over de novo drug development, the most important one being shorter drug development timelines. In the last two decades, drug repositioning has made tremendous impact on drug development technologies. In this review, we focus on the recent advances in drug repositioning technologies and discuss the repositioned drugs used for inflammatory diseases such as sepsis, asthma, and atopic dermatitis.

A case of Chronic Pelvic Inflammatory Disease (만성골반염에 대한 임상 1례 보고)

  • Ban, Hye-Ran;Lee, Jin-A;Cho, Seong-Hee
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.18 no.1
    • /
    • pp.253-261
    • /
    • 2005
  • This study was designed to evaluate the effects of oriental medicine therapy on a chronic pelvic inflammatory disease. The patient was admitted to the OBGY department of Dong-Shin University in Kwang-Ju, on September 15, 2004 and remained until October 20, 2004. She was treated with herbal medicine, herbal retention enema, herbal acupuncture etc. After treatment, improvement was seen in pelycalgia, low abdomen pain, dysuria, leukorrhea. The study suggests that oriental medicine therapy is significantly effective in the treatment of chronic pelvic inflammatory disease.

  • PDF

Single-Cell Genomics for Investigating Pathogenesis of Inflammatory Diseases

  • Seyoung Jung;Jeong Seok Lee
    • Molecules and Cells
    • /
    • v.46 no.2
    • /
    • pp.120-129
    • /
    • 2023
  • Recent technical advances have enabled unbiased transcriptomic and epigenetic analysis of each cell, known as "single-cell analysis". Single-cell analysis has a variety of technical approaches to investigate the state of each cell, including mRNA levels (transcriptome), the immune repertoire (immune repertoire analysis), cell surface proteins (surface proteome analysis), chromatin accessibility (epigenome), and accordance with genome variants (eQTLs; expression quantitative trait loci). As an effective tool for investigating robust immune responses in coronavirus disease 2019 (COVID-19), many researchers performed single-cell analysis to capture the diverse, unbiased immune cell activation and differentiation. Despite challenges elucidating the complicated immune microenvironments of chronic inflammatory diseases using existing experimental methods, it is now possible to capture the simultaneous immune features of different cell types across inflamed tissues using various single-cell tools. In this review, we introduce patient-based and experimental mouse model research utilizing single-cell analyses in the field of chronic inflammatory diseases, as well as multi-organ atlas targeting immune cells.

Clinical report on a patient with chronic PID (만성골반염(慢性骨盤炎) 환자에 대한 한방치료(韓方治療) 치험 1례(例))

  • Je, Yun-Mo;Yoo, Dong-Youl
    • Journal of Haehwa Medicine
    • /
    • v.21 no.1
    • /
    • pp.109-115
    • /
    • 2012
  • Purpose : This study was designed to evaluate the effects of oriental medicine therapy on a chronic PID(pelvic inflammatory disease). Methods : This patient was treated with oriental medicine of Danchisoyosan(丹梔逍遙散), acupuncture at Qihai(氣海), Guanyuan(關元), Zhongji(中極), Sanyinjiao(三陰交) and Zigong(子宮) and moxibution at Zhongwan(中脘), Guanyuan(關元). Results : After the oriental medical treatments such as oriental medicine, acupuncture and moxibution, improvement was seen in the patient's symptoms such as lower abdomen pain, leukorrhea and chronic fatigue syndrome. Conclusion : This results indicates that the oriental treatment is effective in the treatment of chronic pelvic inflammatory disease.

Review of Randomized Controlled Trials Research of Gyejibongnyeong-hwan and Gyejibongnyeong-hwan gagam for Chronic Pelvic Inflammatory Disease (만성 골반 염증성 질환의 계지복령환 및 계지복령환 가감방 투여에 대한 중의학 연구 동향 : 무작위 대조군 임상 연구를 중심으로)

  • Yeon-Soo Jung;Young-Jin Yoon;Hee-Yoon Lee;Jang-Kyung Park
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.36 no.3
    • /
    • pp.78-94
    • /
    • 2023
  • Objectives: The purpose of this study is to review the trends of clinical trials of traditional herbal medicine Gyejibongnyeong-hwan for chronic pelvic inflammatory disease in CNKI. Methods: We searched relevant studies using Chinese National Knowledge Infrastructure (CNKI). Data retrieval was carried out by December 20th, 2021. We analyzed characteristics of study subjects, treatment period, composition of prescription, outcome and adverse event of selected studies and the risk of bias was assessed by using Cochrane's risk of bias tool. Results: Among the total 988 studies, 10 studies met the inclusion criteria. All of the studies were randomized controlled studies and written in Chinese. In all studies, Gyejibongnyeong-hwan was effective in improving chronic pelvic inflammatory disease. Conclusions: This study suggests that Gyejibongnyeong-hwan can be effective in treating chronic pelvic inflammatory disease compared to antibiotics treatment. Further large and well-established randomized placebo controlled trials will be needed.

Clinical study on one case of a patient with chronic PID (만성골반염(慢性骨盤炎) 환자에 대한 치험일례(治驗一例))

  • Seo, Ji-Young;Kim, Yoon-Sang;Lim, Eun-Mee
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.15 no.4
    • /
    • pp.218-227
    • /
    • 2002
  • Pelvic Inflammatory Disease(PID) is a spectrum of inflammatory disorders of the female genital tract involving at least the endrometrium and may include the fallopian tubes, ovaries, and pelvic cavity. Women with PID acutely experience pain and are at risk for sepsis; however, the long-term complications such as chronic pelvic pain, organic changes like chronic salpingitis, adhesions, etc., and the significant increases in ectopic pregnancy and infertility are more important and hard to control. This study is about one patient who has chronic PID with inflammatory pelvic mass. The patient was treated with retention enema therapy which use herbs effective for reducing inflammation, resolution abdominal mass, promoting blood circulation. Also, treated with herbal medication of Danchisoyosan(丹梔逍遙散) and Moxibution at Zhongwan(中脘), Guanyuan(關元). After total treatment for three months, the patient's symptoms are improved and the size of inflammatory pelvic mass is reduced. This results indicates that the combination treatment, especially the retention enema therapy is effective on reducing symptoms of PID and the size of secondary inflammatory organic changes.

  • PDF